Lumida
/ADUS
⌘K
Addus Homecare Corp

Addus Homecare Corp

ADUS
$120.71USD-0.31%-0.38 today

MARKET CAP

2.3B

P/E (TTM)

22.3x

FWD P/E

DAY RANGE

$121 – $123

52W RANGE

$88
$124

AI Summary

Stalk
Buy NowMedium

Buy now to participate in the urgent Lockout Rally continuation as ADUS breaks above the 52-week high on expanding volume and forced short-covering dynamics, supported by rising EMAs and constructive RSI.

  • Q2 EPS $1.73 (+2.4% vs. est); net income $27.6M (+25% YoY)
  • Bank debt reduced by $64.3M, strengthening acquisition capacity
  • COO departure risks leadership continuity during key expansions
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Addus HomeCare Corporation (NASDAQ:ADUS) is a leading provider of personal home care services and hospice care across the United States. Operating in a sector characterized by a growing demand for senior care services, Addus has established a prominent position through strategic acquisitions and a focus on expanding geographical coverage. The company's commitment to enhancing its service offerings in personal care and home health positions it well to capitalize on the aging population trend, driving further growth within the home healthcare industry.

Bull says

  • Q2 EPS $1.73 (+2.4% vs. est); net income $27.6M (+25% YoY)
  • Bank debt reduced by $64.3M, strengthening acquisition capacity
  • Renaissance stake up 64.9%; analysts rate “Moderate Buy” with ~9% upside
  • Q2 revenue +8.0% YoY; projecting 4.6% annual revenue growth next 3 years
  • High earnings yield and low leverage support valuation resilience
  • Positive momentum driven by strategic acquisitions and operational gains

Bear says

  • COO departure risks leadership continuity during key expansions
  • Reimbursement policy exposure could dent margins and deal pipeline
  • 4.6% projected revenue CAGR may lag industry growth rates
  • Negative dividend yield factor signals potential payout cuts
  • Smaller relative market size may limit scalability vs. peers
  • Declining 13F ownership warns of waning institutional confidence

Investment themes with ADUS

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2024 · Mgmt. Guidance

Updated 05-06-2025bullish

Transcript signals

Bull points

  • Addus had a strong start to 2024, continuing our momentum with an impressive financial and operating performance for the first quarter. Our results included solid year-over-year organic growth of 9.3% in Personal Care Services, well above our long-term expected range of 3% to 5%, but in line with our expectations. This growth reflects steady volumes as well as continued favorable rate support for Personal Care Services in some of our larger markets.
  • We were pleased to see consistent positive year-over-year trends of our hospice business in the first quarter, inclusive of our Tennessee Quality Care acquisition. Our hospice same-store revenue growth of 5.8% was our third consecutive quarter of sequential increase and the highest percentage increase we have seen since prior to the COVID pandemic.
  • With our size and scale and the support of a strong balance sheet, we are well positioned to execute our strategy, and we are optimistic we will see attractive acquisition opportunities in 2024.

Bear points

  • Same-store revenue for our Home Health Services, which is 6% of our business, was down 15.1% from the same period a year ago as we continue to intentionally limit admissions from payers with less favorable reimbursement rates.
Read full transcript analysis ›